OSUR — OraSure Technologies Share Price
- $231.69m
- -$35.92m
- $185.83m
- 82
- 63
- 19
- 55
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.56 | ||
Price to Tang. Book | 0.66 | ||
Price to Free Cashflow | 9.83 | ||
Price to Sales | 1.25 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -6.33% | ||
Return on Equity | -4.64% | ||
Operating Margin | -15.2% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 171.72 | 233.67 | 387.48 | 405.47 | 185.83 | 133.98 | 144.1 | 3.75% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
OraSure Technologies, Inc. provides point-of-care and home diagnostic tests and sample management solutions. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV, Hepatitis C and Syphilis that are performed on a rapid basis at the point of care. Its business also includes sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
Directors
- Michael Celano NEC (62)
- Stephen Tang PRE (60)
- Scott Gleason CFO
- Lisa Nibauer EVP (53)
- Kathleen Weber EVP (54)
- Agnieszka Gallagher CCO (48)
- Michele Miller VFN (47)
- Mara Aspinall IND (58)
- James Datin IND (58)
- Nancy Gagliano IND (62)
- Eamonn Hobbs IND (62)
- Ronny Lancaster IND (69)
- Lelio Marmora IND (54)
- David Shulkin IND (61)
- Anne Whitaker IND (54)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 5th, 2000
- Public Since
- November 17th, 1986
- No. of Shareholders
- 22,476
- No. of Employees
- 501
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Global Select Market
- Shares in Issue
- 77,488,414

- Address
- 220 E First St, BETHLEHEM, 18015
- Web
- https://www.orasure.com/
- Phone
- +1 5036416115
- Contact
- Jason Plagman
- Auditors
- KPMG LLP
Upcoming Events for OSUR
Q1 2025 OraSure Technologies Inc Earnings Call
OraSure Technologies Inc Annual Shareholders Meeting
OraSure Technologies Inc Annual Shareholders Meeting
Q2 2025 OraSure Technologies Inc Earnings Release
Similar to OSUR
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
As of Today at 22:28 UTC, shares in OraSure Technologies are trading at $2.99. This share price information is delayed by 15 minutes.
Shares in OraSure Technologies last closed at $2.99 and the price had moved by -43.16% over the past 365 days. In terms of relative price strength the OraSure Technologies share price has underperformed the S&P500 Index by -47.53% over the past year.
The overall consensus recommendation for OraSure Technologies is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreOraSure Technologies does not currently pay a dividend.
OraSure Technologies does not currently pay a dividend.
OraSure Technologies does not currently pay a dividend.
To buy shares in OraSure Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $2.99, shares in OraSure Technologies had a market capitalisation of $231.69m.
Here are the trading details for OraSure Technologies:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: OSUR
Based on an overall assessment of its quality, value and momentum OraSure Technologies is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in OraSure Technologies is $5.00. That is 67.22% above the last closing price of $2.99.
Analysts covering OraSure Technologies currently have a consensus Earnings Per Share (EPS) forecast of -$0.62 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like OraSure Technologies. Over the past six months, its share price has underperformed the S&P500 Index by -21.8%.
As of the last closing price of $2.99, shares in OraSure Technologies were trading -23.42% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The OraSure Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.99.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
OraSure Technologies' management team is headed by:
- Michael Celano - NEC
- Stephen Tang - PRE
- Scott Gleason - CFO
- Lisa Nibauer - EVP
- Kathleen Weber - EVP
- Agnieszka Gallagher - CCO
- Michele Miller - VFN
- Mara Aspinall - IND
- James Datin - IND
- Nancy Gagliano - IND
- Eamonn Hobbs - IND
- Ronny Lancaster - IND
- Lelio Marmora - IND
- David Shulkin - IND
- Anne Whitaker - IND